|
Home
> Insight > Conditions &
Disease's > Posterior Eye Disease > Retinitis Pigmentosa

Retinitis pigmentosa is a rare disease
in which the light-sensitive retina of the eye slowly and progressively
degenerates, eventually causing blindness. Retinitis pigmentosa
is an inherited condition of the retina in which specific photoreceptor
cells, called rods, degenerate. The loss of function of these rod
cells diminishes a patient's ability to see in dim light and with
time can also diminish their peripheral vision. Retinitis pigmentosa
is probably caused by mutations in at least ten different genes.
Retinal appearance of a patient with retinitis pigmentosa
caused by a mutation in the rhodopsin gene. The brown pigment in
the lower half of the eye is the finding that gives the condition
its name. The sharp demarcation between the normal retina above
and the abnormal retina below is characteristic of rhodopsin mutations.

Not much is known about the cause
of retinitis pigmentosa, except that it is inherited. Sometimes
the disease is dominant, meaning only one gene needs to come from
a parent for the child to develop the disease. Other times the disease
is X-linked, meaning that only one gene passed from the mother will
cause the child to develop retinitis pigmentosa. On occasion, males
will develop a related hearing loss. Rods, the light-sensing cells
of the retina that are responsible for vision in low amounts of
light, gradually deteriorate so seeing at night and in low levels
of light becomes more difficult.

Early signs of retinitis pigmentosa
are worsening night vision and a shrinking field of vision. This
disease often begins in early childhood and worsens over time. During
later stages of retinitis pigmentosa, a small area of central vision
remains, along with slight peripheral vision.
Patients with retinitis pigmentosa
(RP) may present with varying symptoms. The onset is often gradual
and insidious, and many patients fail to recognize the manifestations
of this condition until it has progressed significantly. When patients
do report symptoms, they commonly include difficulty with night
vision (nyctalopia) as well as loss of peripheral vision.
Many patients with RP also experience
photopsiae as the disorder progresses; typically they report small
flashes of light or a twinkling, shimmering sensation in the midperipheral
or peripheral field. These are believed to represent aberrant electrical
impulses from the degenerating retina.

Retinitis pigmentosa has no treatment
or cure, although some practitioners believe that vitamin A may
slightly delay vision loss. Occupational therapy may be wise before
much of vision is lost. It may be easier to learn how to work around
vision loss while vision is still available.
Two treatments for the disease
are currently under investigation. The first is an intraocular lens
retinal prosthesis, in which a computer chip is implanted in the
retina to determine if electrical stimulation of the retina aids
the vision of people diagnosed with retinitis pigmentosa and age-related
macular degeneration. To date, about 15 procedures have been performed
on an experimental basis, and research is expected to take at least
five more years.
The second is a new use for the
drug diltiazem, commonly known by the trade names Cardizem and Tiazac,
which is prescribed for high blood pressure and angina. Diltiazem
has delayed blindness in mice with a condition resembling retinitis
pigmentosa. Researchers caution retinitis pigmentosa patients not
to begin taking the drug on their own in hopes of preventing vision
loss, and note that the drug levels given to the mice were much
higher than what is prescribed for heart conditions. Side effects
of the drug include headache, dizziness and a slowed heartbeat.
Researchers are unsure if the diltiazem will be as effective in
slowing human blindness as it has in mice.
For more information of Retinitis Pigmentosa and
its treatment:
Source(s): All above information
& images are based on an article written by Gretchyn
Bailey allaboutvision.com and from other sources. All rights
reserved by respective owners.
For our full credit and copyright
information please view our Credit
List.
Disclaimer: Any information displayed here is just for educational
purposes, and may not be taken as an expert advice and should not
be applied in life without consulting your eye doctor/specialist. We here
by take no responsiblity of the accuracy of the above content as they have
been taken from various sources.
|